- Home
- ARDX vs PTA Comparison
ARDX vs PTA Comparison
Compare ARDX & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- PTA
- Stock Information
- Founded
- ARDX 2007
- PTA 2020
- Country
- ARDX United States
- PTA United States
- Employees
- ARDX N/A
- PTA N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- PTA Trusts Except Educational Religious and Charitable
- Sector
- ARDX Health Care
- PTA Finance
- Exchange
- ARDX Nasdaq
- PTA Nasdaq
- Market Cap
- ARDX 1.3B
- PTA 1.0B
- IPO Year
- ARDX 2014
- PTA N/A
- Fundamental
- Price
- ARDX $3.64
- PTA $19.20
- Analyst Decision
- ARDX Strong Buy
- PTA
- Analyst Count
- ARDX 8
- PTA 0
- Target Price
- ARDX $10.19
- PTA N/A
- AVG Volume (30 Days)
- ARDX 6.4M
- PTA 159.2K
- Earning Date
- ARDX 05-01-2025
- PTA 01-01-0001
- Dividend Yield
- ARDX N/A
- PTA 8.31%
- EPS Growth
- ARDX N/A
- PTA N/A
- EPS
- ARDX N/A
- PTA N/A
- Revenue
- ARDX $361,706,000.00
- PTA N/A
- Revenue This Year
- ARDX $15.74
- PTA N/A
- Revenue Next Year
- ARDX $34.56
- PTA N/A
- P/E Ratio
- ARDX N/A
- PTA N/A
- Revenue Growth
- ARDX 127.33
- PTA N/A
- 52 Week Low
- ARDX $3.62
- PTA $15.84
- 52 Week High
- ARDX $9.20
- PTA $19.67
- Technical
- Relative Strength Index (RSI)
- ARDX 32.40
- PTA 58.58
- Support Level
- ARDX $3.62
- PTA $18.86
- Resistance Level
- ARDX $5.65
- PTA $19.24
- Average True Range (ATR)
- ARDX 0.31
- PTA 0.26
- MACD
- ARDX -0.15
- PTA 0.10
- Stochastic Oscillator
- ARDX 6.53
- PTA 95.46
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.